首页 | 本学科首页   官方微博 | 高级检索  
     


The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine
Authors:Richtand N M  Logue A D  Welge J A  Perdiue J  Tubbs L J  Spitzer R H  Sethuraman G  Geracioti T D
Affiliation:Cincinnati Veterans Affairs Medical Center, Department of Psychiatry, V-116A, 3200 Vine Street, Cincinnati, OH 45220, USA. neil.richtand@uc.edu
Abstract:Behavioral sensitization is a well-studied model of behavioral plasticity mediated at least in part by dopaminergic systems believed to play an important role in several psychiatric conditions. In the rodent, locomotion is regulated by the opposing balance of D3 and D2 receptors, with D2 activation increasing and D3 stimulation inhibiting locomotion. However, receptor occupancy of D3 dopamine receptors is far greater than D2 or D1 occupancy at typical post-stimulant dopamine concentrations. We therefore hypothesized that tolerance of D3 receptor inhibition of locomotion contributes to the development of sensitization. To test this hypothesis, we examined the effect of the D3 receptor antagonist nafadotride on sensitization. As predicted, nafadotride inhibits augmentation of the locomotion response to repetitive amphetamine. This finding is consistent with the proposed model of adaptive down-regulation of D3 dopamine receptor function contributing to the development of behavioral sensitization.
Keywords:Stimulant drugs   Amphetamine   Psychosis   Behavioral sensitization   Dopamine D3 receptor   Nafadotride
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号